SCHEMBL23795263

SCHEMBL23795263

CC1(c2cc(Br)cc(Br)c2)CC(c2ccccc2)(c2cc(Br)cc(Br)c2)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
PLIN1 O60240 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PLIN5 Q00G26 1/20 0.35
ABHD5 Q8WTS1 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ADRB2 P07550 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SIGMAR1 Q99720 1/20 0.33
TP53 P04637 4/20 0.33
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
HTR6 P50406 1/20 0.31
FSHR P23945 1/20 0.31
LMNA P02545 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21925728 0.84 MEN1 (0.39) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL23795254 0.84 MEN1 (0.39) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL21925732 0.84 MEN1 (0.39) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL6899070 0.83 MEN1 (0.45) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL21925730 0.74 FSHR (0.43) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL23795275 0.74 TP53 (0.49) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL21925724 0.74 TP53 (0.49) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL23795303 0.74 TP53 (0.43) MAPTMEN1KMT2AADRB2NPSR1
SCHEMBL23795365 0.74 MAPT (0.35) MAPTTDP1PLIN1ALDH1A1PLIN5
SCHEMBL31114350 0.74 MAPT (0.35) MAPTTDP1PLIN1ALDH1A1PLIN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics DOTTIKON ES HOLDING AG (CH) 2024-10-22 US disclosed
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2022-01-06 US disclosed
EP-3877357-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS NR0B2, KCNJ2, TRRAP MAPT 2927/4885TDP1 2481/4885PLIN1 4447/4885
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics NR0B2, KCNJ2, TRRAP MAPT 2927/4885TDP1 2481/4885PLIN1 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.